If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreo Medical Regulatory News (CREO)

Share Price Information for Creo Medical (CREO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 34.75
Bid: 34.50
Ask: 35.00
Change: 0.00 (0.00%)
Spread: 0.50 (1.449%)
Open: 34.75
High: 34.75
Low: 34.75
Prev. Close: 34.75
CREO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed Acquisition

14 Dec 2006 09:17

China Real Estate Opportunities SA14 December 2006 CHINA REAL ESTATE OPPORTUNITIES S.A. PROPOSED ACQUISITION OF BEIJING PROPERTY China Real Estate Opportunities S.A. ("CREO") announces that it has todayexchanged conditional contracts for the acquisition of a property in Beijing,China. The property is a prime mixed-use development located in central Beijing, knownas the Xidan Centrepoint Shopping Centre, Office Complex and Hotel. CREO hascommitted to purchase 100% of the property subject to a number of conditionsincluding the construction of the project being substantially complete and CREOshareholder approval. The vendor is a wholly-owned subsidiary of ChinaMetallurgical Construction (Group) Corp, one of China's largest conglomeratesand a company controlled by China's central government. Xidan Centrepoint is located in a prime location on one of Beijing's busiestshopping and commercial streets, known as Xidan. The street runs north-southapproximately 1km directly west of the Forbidden City and Tiananmen Square andapproximately 1km directly to the east of the Financial Street district. Theproperty lies less than 100 metres north of Xidan (underground) Station. The property covers a site area of 16,073 square metres and will when completehave a total gross built floor area of approximately 194,949 square metres over15 floors above ground and 4 floors below ground. Of this area, approximately102,945 square metres is designated for retail, a 372 room luxury hotelcomponent comprises another 32,126 square metres, while an office component is afurther 15,858 square metres. 1,000 car parking spaces and ancillary uses aredesignated for the remaining 44,020 square metres. The property is currently under construction and is expected to be completed byDecember 2007. CREO has agreed to pay a total price of RMB 3,742,520,000(approximately £243.1m or €361.9m*) payable in stages as title to the propertyis acquired and as the property is completed and leased out. An initial depositwill be paid by the Company from existing cash resources amounting to RMB187,876,000 (£12.2 million or €18.2 million). Since this acquisition will be a reverse takeover under the AIM rules, pendingshareholder approval and completion of the acquisition, the shares of theCompany were suspended from trading on AIM with effect from 10.00 a.m. on 8thDecember at the request of the Company. A circular will be sent to CREO shareholders in due course detailing the termsof the proposed acquisition along with an admission document. It is expectedthat the shares in CREO will remain suspended until the acquisition has beenapproved. CREO will be undertaking a fund raising in the New Year by way of aplacing of new shares to the market and a further announcement regarding thiswill be made in due course CREO is majority owned by the directors of Treasury Holdings ("Treasury"), RealEstate Opportunities Ltd ("REO") and the directors of REO. It will be proposedin the forthcoming circular that CREO will be managed by Treasury, Ireland'slargest property developer. Treasury owns 58.5% of REO's ordinary shares. Treasury controls a large property investment and development portfolio acrossEurope as well as very substantial interests in environmental technology,renewable energy and waste management. Treasury started operations in China in2002 working with Shanghai Industrial Investment Company, a company owned by theShanghai Municipal Government, on the development of the Chongming Eco City justoutside Shanghai. Since then, Treasury has expanded its business considerablyboth in Shanghai and Beijing and 3 of the 6 executive main Board Treasurydirectors are now resident in China to grow the business. CREO was formed in December 2005 to investigate real estate opportunities inChina. *Exchange rate £1:RMB 15.39, €1 EUR:RMB 10.34 Enquiries to: CREORay Horney, Chairman Tel: +44 (0) 1273 775225 Treasury HoldingsRob Tincknell Tel: + 86 137 889 83016 (N.B GMT + 8hrs) Teather & GreenwoodPaul Fincham Tel: +44 (0)20 7426 7736 Bankside Consultants (UK)Simon RothschildOliver Winters Tel: +44 (0)20 7367 8888 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
7th May 20247:00 amRNSCreo Medical receives King’s Award for Enterprise
25th Apr 20247:00 amRNSNotice of Results
24th Apr 20247:00 amRNSNHS Speedboat data demonstrates savings
20th Mar 20244:52 pmRNSHolding(s) in Company
19th Mar 20247:00 amRNSWelsh Labour Leader visits Creo’s facilities
13th Mar 20243:05 pmRNSHolding(s) in Company
11th Mar 20242:00 pmRNSLTIP Awards
6th Mar 20244:35 pmRNSHolding(s) in Company
1st Mar 20247:00 amRNSMicrowave Lung Ablation Update
7th Feb 20249:12 amRNSTrading Update - Replacement
7th Feb 20247:00 amRNSTrading Update
5th Feb 20247:00 amRNSStrategic Collaboration with Khalifa University
31st Jan 20247:00 amRNSSpeedboat® UltraSlim roll-out reaches Asia Pacific
22nd Jan 20247:00 amRNSAward of Shares under Share Incentive Plan
10th Jan 20247:00 amRNSFirst use of Speedboat® UltraSlim in Latin America
15th Dec 20237:00 amRNSFirst use of Speedboat® UltraSlim in the USA
13th Dec 20237:00 amRNSFirst European Speedboat® UltraSlim procedure
7th Nov 20237:00 amRNSCapital Markets Day
1st Nov 20237:00 amRNSSpeedboat® UltraSlim: US FDA Clearance
25th Oct 20237:00 amRNSSB UltraSlim: EU launch accelerated by 18 months
16th Oct 202310:16 amRNSChange of Nominated Adviser and Joint Broker
12th Oct 20237:00 amRNSInvestor Presentation
12th Sep 20237:00 amRNSHalf-year Report
5th Sep 20237:00 amRNSNotice of Results
16th Aug 20237:00 amRNSRoyal Oldham SSD service update
3rd Aug 20237:00 amRNSHalf Year Trading Update
28th Jul 20237:00 amRNSTotal Voting Rights
24th Jul 202310:40 amRNSAward of Shares under Share Incentive Plan
6th Jul 202311:33 amRNSIssue of Equity and TVR
27th Jun 20231:15 pmRNSResult of AGM
27th Jun 20237:00 amRNSAGM Statement & Directorate Succession Planning
26th Jun 20237:00 amRNSFirst upper GI Speedboat procedure in Europe
22nd Jun 20237:00 amRNSAppointment of Marco Scarci
19th Jun 20237:00 amRNSSpeedboat Inject upper GI clearance in Europe
1st Jun 20237:00 amRNSSpeedboat™ Inject selected by NICE for assessment
26th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
23rd May 20237:00 amRNSFirst in-human milestone for MicroBlate™ Flex
17th May 20237:00 amRNSRoyal Oldham Hospital Agreement
15th May 20237:00 amRNSAttendance at Digestive Disease Week
26th Apr 20237:00 amRNSFinal Results
14th Apr 20237:00 amRNSAlbyn Medical earn out update
31st Mar 202310:45 amRNSTotal Voting Rights
31st Mar 20237:00 amRNSMicroBlate™ Flex clinical study
13th Mar 20236:13 pmRNSDirector/PDMR and PCA Share Dealings
13th Mar 20237:00 amRNSHolding(s) in Company
8th Mar 202310:25 amRNSResult of GM
6th Mar 202311:05 amRNSSecond Price Monitoring Extn
6th Mar 202311:00 amRNSPrice Monitoring Extension
21st Feb 202310:29 amRNSHolding(s) in Company
17th Feb 20232:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.